Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/BLAB stock hub

CSE/BLAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/BLABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.8M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/BLAB

In the news

Latest news · CSE/BLAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/E1.7

P25 7.4P50 15.6P75 34.3

ROE67.8

P25 -121.5P50 -40.9P75 0.5

ROIC-50

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/BLAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

CAD

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	0%
Employees Change Percent	0
Enterprise value	CAD -1.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA11042D1087
Last refreshed	2026-05-10
Market cap	CAD 13.8M
Price	CAD 0.09
Price currency	CAD
Sector	Healthcare
Sic	8734
Symbol	cse/BLAB
Website	https://britannia.life

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	148.55%
EV Earnings	-0.09x
P/B ratio	0.8x
P/E ratio	1.74x
P/S ratio	87.47x
PE Ratio3 Y	4.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-118.69%
Gross Profit	CAD -187,151
Gross Profit Growth Q	-42.17%
Net Income	CAD 20.5M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Pretax Margin	6,022.42%
Profit Margin	12,993.71%
Profitable Years	1
ROA	-7.05
Roa5y	-0.64
ROCE	-14.44
ROE	67.82
Roe5y	-80.28
ROIC	-49.99
Roic5y	-4.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.45%
Cagr3y	-10.86%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	-28.55x
Revenue Growth Q	-61.16x
Revenue Growth Years	0x
Revenue Growth3 Y	-71.06x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.01
Assets	CAD 22.1M
Cash	CAD 15.9M
Current Assets	CAD 17M
Current Liabilities	CAD 4.8M
Debt	CAD 248,559
Debt Equity	CAD 0.01
Equity	CAD 17.2M
Interest Coverage	-542.5
Liabilities	CAD 4.8M
Long Term Assets	CAD 5.1M
Long Term Liabilities	CAD 49,960
Net Cash	CAD 15.6M
Net Cash By Market Cap	CAD 113
Net Debt Equity	CAD -0.91
Tangible Book Value	CAD 17.2M
Tangible Book Value Per Share	CAD 0.11
WACC	3.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.55
Net Working Capital	CAD -3.5M
Quick ratio	3.44
Working Capital	CAD 12.2M
Working Capital Turnover	CAD 0.11

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.43%
200-day SMA	0.08
3Y total return	-29.17%
50-day SMA	0.09
50-day SMA vs 200-day SMA	50over200
All Time High	0.32
All Time High Change	-73.44%
All Time High Date	2021-11-18
All Time Low	0.03
All Time Low Change	183.33%
All Time Low Date	2023-12-05
ATR	0
Beta	-0.07
Beta1y	-1.94
Beta2y	-1.18
Ch YTD	-5.56
High	0.09
High52	0.14
High52 Date	2025-10-06
High52ch	-39.29%
Low	0.08
Low52	0.06
Low52 Date	2025-08-14
Low52ch	41.67%
Ma50ch	-10.24%
Price vs 200-day SMA	1.07%
RSI	41.37
RSI Monthly	49.65
RSI Weekly	48.9
Sharpe ratio	1.05x
Sortino ratio	1.93
Tr YTD	-5.56
Tr1m	-5.56%
Tr1w	-5.56%
Tr3m	-15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.5M
Operating margin	-1,582.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	101,860,558%
Net Borrowing	-1,120,988
Shares Insiders	37.22%
Shares Out	162,254,339
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	114,614.4x
Bv Per Share	0.11
Ch1m	-5.56
Ch1w	-5.56
Ch1y	21.43
Ch3m	-15
Ch3y	-29.17
Ch6m	-19.05
Change	6.25%
Change From Open	6.25
Close	0.08
Days Gap	0
Depreciation Amortization	103,175
Dollar Volume	14,365
Earnings Date	2026-07-30
EBIT	CAD -2.5M
EBITDA	CAD -2.4M
EPS	CAD 0.13
F Score	2
Financing CF	-1,307,222
Fiscal Year End	March
Graham Number	0.54928
Graham Upside	546.2
Income Tax	CAD 1.7M
Investing CF	6,307,936
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2021-11-18
Last Split Type	Reverse
Ma150	0.09
Ma150ch	-5.56%
Ma20	0.09
Ma20ch	-4.28%
Net CF	827,957
Next Earnings Date	2026-07-30
Open	0.08
Position In Range	100
Ppne	94,996
Price Date	2026-05-08
Ptbv Ratio	0.8
Relative Volume	1.47x
Revenue	157,677x
Tax By Revenue	1,061.73x
Tax Rate	17.63%
Tr6m	-19.05%
Volume	169,000
Z Score	1.74

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/BLAB pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/BLAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/BLAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+37.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

CSE/BLAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.4

Neutral momentum band

Price vs 200-day MA

+1.1%

50/200-day relationship not available

Beta (5Y)

-0.07

Less volatile than the market

Sharpe ratio

1.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/BLAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/BLAB stock rating?

cse/BLAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/BLAB analysis?

The full report lives at /stocks/cse/BLAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/BLAB?

The latest report frames cse/BLAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/BLAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.